Retatrutide: A New Approach to Weight Management
Unlike medications that target one or two hormone pathways, retatrutide activates three receptors: GLP-1, GIP, and glucagon.
Retatrutide: A New Approach to Weight Management
Unlike medications that target one or two hormone pathways, retatrutide activates three receptors: GLP-1, GIP, and glucagon.
Insurance, financing, & out-of-pocket options
Retatrutide for Weight loss
Retatrutide is an investigational medication being studied for its potential to support significant weight loss and improve metabolic health. Unlike medications that target one or two hormone pathways, retatrutide activates three receptors: GLP-1, GIP, and glucagon.
This unique triple-action approach may help address several factors involved in weight management, including appetite, blood sugar regulation, fat metabolism, and energy expenditure.
Retatrutide is currently investigational and has not been approved by the FDA for routine medical use. Its safety and effectiveness are still being evaluated in clinical trials.
Why the Triple-Action Approach Is Different
Semaglutide primarily targets the GLP-1 receptor, while tirzepatide targets GLP-1 and GIP receptors. Retatrutide adds activation of the glucagon receptor, creating a three-pathway approach that researchers are studying for its potential to produce greater weight loss and broader metabolic benefits.
Why the Triple-Action Approach Is Different
Semaglutide primarily targets the GLP-1 receptor, while tirzepatide targets GLP-1 and GIP receptors. Retatrutide adds activation of the glucagon receptor, creating a three-pathway approach that researchers are studying for its potential to produce greater weight loss and broader metabolic benefits.
How Retatrutide Works
Retatrutide works by activating three naturally occurring hormone pathways
GLP-1 Receptor signaling can help:
Reduce appetite and food intake
Slow stomach emptying
Support healthy blood sugar regulation
Enhance insulin secretion when glucose levels are elevated
GIP Receptor signaling may:
Enhance the body's insulin response
Support glucose regulation
Influence fat metabolism and energy balance
Glucagon Receptor receptor activation may:
Increase energy expenditure
Promote the breakdown of stored fat
Influence how the body uses and stores energy.
Dual Hormone Action
Activates three receptors: GLP-1, GIP, and glucagon
Deeper Appetite Suppression
Stronger fullness signal reported in trials
Improved Insulin Sensitivity
Supports blood sugar regulation alongside weight loss
3 Steps to your first dose
Every step is reviewed by a licensed provider before you begin
1
Complete your assessment
A short health history and goals questionnaire, done online in under 10 minutes.
2
Provider review
A licensed provider reviews your history and confirms eligibility, usually within 24 hours.
3
Begin your plan
Your first dose ships or is administered in-office, with weekly check-ins to adjust as needed.
Medical Expertise
Every plan is reviewed and adjusted by licensed providers experienced specifically in GLP-1 therapy.
Comprehensive Care
Dosing, side-effect management, and progress tracking — handled in one continuous relationship, not a one-time script.
Personalized Results
No fixed protocol. Your plan is shaped around your labs, response, and goals from week one.
What Patients Notice, Beyond the Scale
Patients on a supervised tirzepatide plan often notice changes across several areas of health.
Metabolic & insulin health
Improved insulin sensitivity, better blood sugar regulation, reduced fat storage are often the most pronounced changes.
Mood & mental clarity
Enhanced emotional health, improved mood, mental clarity, balanced hormones, higher self-esteem.
Cardiometabolic health
Lower blood pressure, lower triglycerides, reduced risk of heart disease, improved insulin resistance, lower risk for certain cancers.
Energy & physical function
More energy, better sleep, improved mobility and reduced pain, fewer headaches, stronger immune response.
Daily life & independence
Improved eating habits, reduced need for other prescription medications, reversal of certain weight-related health conditions.
Confidence & relationships
Enhanced intimacy/sex life, improved relationships with family, friends, and coworkers, feeling and looking better.
What Clinical Trials Have Shown
Clinical research has demonstrated promising results for retatrutide. In a Phase 2 clinical trial, participants receiving the highest studied dose experienced approximately 24% average weight loss at 48 weeks. More recent clinical research has continued to evaluate retatrutide's potential effects on body weight and metabolic health. Results have also shown improvements in measures such as:
Body weight and waist circumference
Blood sugar and insulin sensitivity
Triglycerides and other metabolic markers
Liver fat
Blood pressure
These results are encouraging, but ongoing research is needed to fully understand the medication's long-term benefits and risks.
Retatrutide treatments Plans for every budget
Free treatment on first visit with doctor’s approval
Qualified professionals for in-person and virtual support
Lifetime body scan with Skyku
Weekly accountability support
Home delivery & in-office visit options
Hear From Our Patients
"I embarked on my weight loss journey three weeks ago, and I’m thrilled to share that everyone at Medi Slim is incredibly knowledgeable and supportive. The products they offer are incredibly helpful, and I’ve already recommended Medi Slim to my friends and family. I’m excited to continue my journey with them and am very pleased with my progress so far."
"I can’t say enough good things about MediSlim! I initially sought them out to lose just a few pounds, but the biggest win for me has been getting my blood sugar levels under control. Their team is professional, knowledgeable, and truly cares about their clients’ health—not just the number on the scale."
"The Medi Slim team is professional, responsive, friendly, and caring! The location is easy to get to with plenty of parking. The office is clean and welcoming. Highly recommend for anyone ready to start their weight loss journey!"
Frequently Asked Questions
How do I take retatrutide?
In clinical trials, retatrutide has been studied as a once-weekly subcutaneous injection. Research protocols have generally used gradual dose escalation to help participants adjust to treatment and reduce gastrointestinal side effects. Clinical-trial dosing should not be interpreted as a recommended dose for individual patients. Any use of an investigational medication should be determined by an appropriately licensed healthcare professional and consistent with applicable laws and regulations.
How is my dose determined?
You start at a low dose and your provider increases it gradually based on your response and any side effects, following standard titration protocols.
What are the potential side effects?
The most commonly reported side effects in clinical studies have been gastrointestinal and may include nausea, vomiting, diarrhea, constipation, and decreased appetite. Other potential effects have been observed during clinical research, including changes in heart rate and other laboratory measurements. As research continues, the full safety profile of retatrutide is still being established.
Is retatrutide FDA approved?
Retatrutide represents an exciting area of ongoing research in obesity and metabolic medicine. By targeting GLP-1, GIP, and glucagon receptors simultaneously, researchers are investigating whether this triple-action approach can provide substantial weight loss along with improvements in important metabolic health measures.
At Medi Slim Weight Loss, we believe patients deserve access to current, evidence-based information about emerging treatments. Our medical team can discuss currently approved weight-management options and help determine which approach may be appropriate for your individual health goals.
Retatrutide is investigational and is not FDA approved for the treatment of obesity or any other medical condition at this time.
Does insurance cover treatment?
Some insurance plans are accepted, and we'll verify your specific coverage before you commit to anything. Self-pay plans and financing are available if you're not covered.
Start Your Online Consultation Today
Complete the form for a pre-qualification, or call (804) 657-4339 to speak with the staff in our local office.
Office hours
Monday – Friday: 9:00 am – 5:00 pm
Saturday: Closed
Sunday: Closed
Useful Links
Copyright 2026. Medi Slim™. All Rights Reserved | Privacy Policy